Maternal use of thyroid hormones in pregnancy and neonatal outcome

Acta Obstetricia et Gynecologica Scandinavica

Volumn 87, Issue 6, 2008, Pages 617-627

  Norstedt Wikner, Birgitta ^a   Skjoøldebrand Sparre, Lottie ^b   Stiller, Carl Olav ^a   Källén, Bengt ^c   Asker, Charlotte ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c UNIVERSITY OF LUND   (Sweden)

Author keywords

Malformations; Maternal outcome; Neonatal outcome; Thyroid hormone substitution

Indexed keywords

THYROID HORMONE; THYROXINE;

ADULT; ARTICLE; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; DIABETES MELLITUS; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE SUBSTITUTION; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; NEWBORN CARE; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; RISK; THIRD TRIMESTER PREGNANCY; THYROTOXICOSIS;

ADULT; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REGISTRIES; THYROID HORMONES;

EID: 45849126466     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340802075103     Document Type: Article

References (30)

1. Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol. 1991;35:41-6.
2. Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trøndelag (HUNT). Eur J Endocrinol. 2000;143:639-47.
3. Becks GP, Burrow GN. Thyroid disease and pregnancy. Med Clin North Am. 1991;75:121-50.
4. Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hochberg Z. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol. 2003;102:232-41.
5. Haddow JE, Palomake GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549-55.
6. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-9.
7. Wolfberg A, Lee-Parritz A, Peller AJ, Lieberman E. Obstetric and neonatal outcomes associated with maternal hypothyroid disease. J Matern Fetal Neonatal Med. 2005;17:35-8.
8. Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol. 2005;63:560-5.
9. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol. 2007;66:309-21.
10. Poppe K, Glinoer D, Tounaye H, Devroey P, van Steirteghem A, Kaufman L, et al. Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab. 2003;88:4149-52.
11. Tan TO, Cheng YW, Caughey AB. Are women who are treated for hypothyroidism at risk for pregnancy complications? Am J Obstet Gynecol. 2006;194:e1-3.
12. Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid. 2005;15:351-7.
13. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7:127-30.
14. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105:239-45.
15. National Board of Health and Welfare. Centre for Epidemiology. The Swedish Medical Birth Register - a summary of content and quality. Available online at http://www.sos.se/FULLTEXT/112/2003-112-3/2003-112-3.pdf (accessed 15 October 2007).
16. The National Board of Health and Welfare. Centre for Epidemiology. Research Report from EpC (2004). Registration of congenital malformations in the Swedish health registers. Available online at http://www.socialstyrelsen.se/ Publicerat/2004/5120/2004-112-1.htm (accessed 15 October 2007).
17. Källén B. A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry, 1985-1989. Eur J Epidemiol. 1995:11:601-6.
18. Miettinen OS. Simple interval estimation of risk ratio. Am J Epidemiol. 1974;100:515-6.
19. Alvarez-Marfany M, Roman SH, Drexler AJ, Robertson C, Stagnaro-Green A. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 1994;79:10-6.
20. Olivieri A, Valensise H, Magnani F, Medda E, De Angelis S, D'Archivio M, et al. High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus. Eur J Endocrinol. 2000;143:741-7.
21. Lapaire O, Hösli I, Zanetti-Daellenbach R, Huang D, Jaeggi C, Gatfield-Mergenthaler S, et al. Impact of fetal-maternal microchimerism on women's health - a review. J Matern Fetal Neonatal Med. 2007;20:1-5.
22. Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L, et al. Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur J Endocrinol. 2006;154:39-45.
23. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA. 2004;292:691-5.
24. Källén B, Finnström O, Nygren KG, Otterblad Olausson P. In vitro fertilization in Sweden: maternal characteristics. Acta Obstet Gynecol Scand. 2005;84:1185-91.
25. Papadopoulos K, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiophatic Addison's disease. Acta Endocrinol (Copenh). 1990;122:472-8.
26. Pop VJ, Wijnen HA, Lapkienne L, Bunivicius R, Vader HL, Essed GG. The relation between gestational thyroid parameters and depression: a reflection of the downregulation of the immune system during pregnancy? Thyroid. 2006;16:485-92.
27. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol. 2007;63:363-73.
28. Peleg D, Cada S, Peleg A, Ben-Ami M. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol. 2002;99:1040-3.
29. Källén BAJ, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003;17:255-61.
30. Robert E, Vollset SE, Botto L, Lancaster PAL, Merlob P, Mastroiacovo P, et al. Malformation surveillance and maternal drug exposure: the MADRE project. Int J Risk Safety Med. 1994;6:75-118.